Alkermes
Alkermes combines drug-research employment with professional development and networking through employee resource groups. Its published framework names the Women Inspired Network and Operation Salute, with participation open to employees who wish to join.
- Specialty Pharma Companies
Overview
Alkermes combines drug-research employment with professional development and networking through employee resource groups. Its published framework names the Women Inspired Network and Operation Salute, with participation open to employees who wish to join. These mechanisms provide professional connection around scientific work without being described as a research fellowship or guaranteed advancement pathway.
The benefits and US employee records supply an operating workforce context. The groups serve distinct purposes, while RISE recognizes contributions reflecting company values. Recognition is not automatically promotion, and network membership does not establish that every research employee receives identical mentoring or career opportunities. The profile keeps the US evidence separate from images or activity concerning colleagues elsewhere.
Published assessment: Top 30 Employers for Research & Innovation Careers 2027 — Alkermes.
Firm facts
| Public identity | Alkermes |
| Institution type | Specialty Pharma Companies institution |
| Primary focus | Specialty Pharma Companies |
Contents
- Activities in published assessments
- Principal activities
- Sector and mandate coverage
- Market position
- Competitive context
- Leadership and governance
- Corporate and public information
- Company structure and assessed businesses
- Rankings and recognition
- Related Economy analysis
- Related institutions and subjects
- Sources and data transparency
Activities in published assessments
Top 30 Employers for Research & Innovation Careers 2027 — Alkermes
Alkermes combines drug-research employment with professional development and networking through employee resource groups. Its published framework names the Women Inspired Network and Operation Salute, with participation open to employees who wish to join. These mechanisms provide professional connection around scientific work without being described as a research fellowship or guaranteed advancement pathway.
The benefits and US employee records supply an operating workforce context. The groups serve distinct purposes, while RISE recognizes contributions reflecting company values. Recognition is not automatically promotion, and network membership does not establish that every research employee receives identical mentoring or career opportunities. The profile keeps the US evidence separate from images or activity concerning colleagues elsewhere.
Top 30 Pharmaceutical & Biotechnology Employers 2027 — Alkermes
Alkermes identifies employee resource groups as mechanisms for professional development and networking, with participation open to employees who wish to join. The Women Inspired Network and Operation Salute have distinct purposes, while the RISE program allows colleagues to recognize contributions reflecting the organization’s values. Its benefits framework also covers health, family and financial needs.
Great Place To Work’s U.S. profile, updated May 2026, reports 92% overall workplace endorsement. A published employee item records 94% agreement: “I am able to take time off from work when I think it's necessary.”
Top 30 Employers for Employee Recognition 2027 — Alkermes
Alkermes’ RISE programme allows colleagues to recognize contributions reflecting organisational values. It sits alongside employee networks with distinct professional and community purposes. Separating recognition from network participation makes the employment proposition clearer: acknowledging a contribution is a different activity from joining a group or obtaining access to professional development.
The assessment uses the U.S. direct-employee evidence and the documented recognition arrangement. Employees pictured or discussed in other countries are not automatically included in that survey population. In a pharmaceutical organisation, a values-linked programme provides a way to acknowledge work across scientific, operational and enabling functions without making scientific reputation itself an employment score.
Top 30 Specialty Pharma Companies 2026 — Alkermes
Alkermes is an established healthcare institution whose principal relevance to this ranking lies in specialty pharma companies. Its inclusion reflects an operating platform that is active, institutionally visible, and sufficiently developed to be assessed alongside other consequential participants in specialty Pharma Companies.
Within this category, the important distinction is not scale alone. Buyers, patients, health systems, life-sciences sponsors, clinicians, or institutional partners—depending on the service—also need evidence of specialist depth, delivery infrastructure, governance, geographic reach, and the ability to support demanding use cases over time. Alkermes contributes a credible combination of these characteristics.
Principal activities
Alkermes is assessed using public institutional information and category-specific editorial research.
Core capability
Specialty Pharma Companies
Client relevance
Category-specific capability, institutional credibility and the ability to support demanding professional, commercial or patient needs.
Execution and verification
Current service scope, leadership, geographic coverage, legal entities and regulated activities should be confirmed directly.
Sector and mandate coverage
Primary category
Specialty Pharma Companies
Institutional context
Coverage reflects the institution’s role in the ranking categories listed below. Precise services, products, jurisdictions, clinical scope and client eligibility should be verified for each use case.
Market position
Alkermes is assessed using public institutional information and category-specific editorial research.
Alkermes is assessed through public institutional information and Ranking News editorial research. Its strongest 2026 result is Tier III.
Competitive context
The relevant peer set varies by category, geography, client segment and mandate. Alkermes should be compared on current category-specific capability, senior involvement, evidence of comparable work, operating resilience and any applicable regulatory or clinical permissions.
Comparable institutions are shown for navigation and market context. Inclusion does not imply identical scale, ownership, geographic coverage, service model or regulatory status.
Leadership and governance
Leadership, ownership, governance and senior-team responsibilities may change. Current information should be verified through authoritative institutional sources.
Corporate and public information
The public-facing organization is identified here as Alkermes. Contracting entities, regulated affiliates, clinical operations, offices and legal permissions may differ by service and jurisdiction.
Corporate and disclosure information
| Organization | Alkermes |
| Verification note | Confirm legal entity, licenses, offices and engagement terms directly before appointment or use. |
Company structure and assessed businesses
Alkermes is a neuroscience-focused biopharmaceutical group. Alkermes plc identifies Ireland as its headquarters, with a Massachusetts corporate office and research center and Ohio manufacturing. The U.S. operating/employer scope associated with Alkermes, Inc. is retained within the group profile rather than treated as a different global headquarters.
Primary sources: company reference 1.
Assessed business: Alkermes, Inc.
Alkermes, Inc. is profiled in The Economy Rankings across Employers for Research & Innovation Careers, Pharmaceutical & Biotechnology Employers, Employers for Employee Recognition.
Business-specific facts retained from the earlier Alkermes, Inc. assessment; dates and locations refer to that business scope.
| Assessed U.S. headquarters / base | Waltham, MA, US |
| Reported business origins | 1987 |
The category profiles below describe the named businesses, products, programmes or employee groups assessed in the linked rankings. Their scope follows each source.
Top 30 Employers for Employee Recognition 2027 — Alkermes, Inc.
Alkermes’ RISE programme allows colleagues to recognize contributions reflecting organisational values. It sits alongside employee networks with distinct professional and community purposes. Separating recognition from network participation makes the employment proposition clearer: acknowledging a contribution is a different activity from joining a group or obtaining access to professional development.
The assessment uses the U.S. direct-employee evidence and the documented recognition arrangement. Employees pictured or discussed in other countries are not automatically included in that survey population. In a pharmaceutical organisation, a values-linked programme provides a way to acknowledge work across scientific, operational and enabling functions without making scientific reputation itself an employment score.
- Employing entity / assessed group: Alkermes, Inc. (assessed U.S. employing group)
- Assessed workforce: U.S. directly employed workforce in provider cohort; contractors and unassessed foreign affiliates excluded.
- Assessed U.S. headquarters / base: Waltham, MA, US
- Reported business origins: 1987
Top 30 Employers for Research & Innovation Careers 2027 — Alkermes, Inc.
Alkermes combines drug-research employment with professional development and networking through employee resource groups. Its published framework names the Women Inspired Network and Operation Salute, with participation open to employees who wish to join. These mechanisms provide professional connection around scientific work without being described as a research fellowship or guaranteed advancement pathway.
The benefits and US employee records supply an operating workforce context. The groups serve distinct purposes, while RISE recognizes contributions reflecting company values. Recognition is not automatically promotion, and network membership does not establish that every research employee receives identical mentoring or career opportunities. The profile keeps the US evidence separate from images or activity concerning colleagues elsewhere.
- Assessed workforce: US employees in documented scientific/research-development work and professional support; role and programme eligibility applies.
Top 30 Pharmaceutical & Biotechnology Employers 2027 — Alkermes, Inc.
Alkermes identifies employee resource groups as mechanisms for professional development and networking, with participation open to employees who wish to join. The Women Inspired Network and Operation Salute have distinct purposes, while the RISE program allows colleagues to recognize contributions reflecting the organization’s values. Its benefits framework also covers health, family and financial needs.
Great Place To Work’s U.S. profile, updated May 2026, reports 92% overall workplace endorsement. A published employee item records 94% agreement: “I am able to take time off from work when I think it's necessary.”
| Ranking | Edition / classification | Assessed scope |
|---|---|---|
| Employers for Research & Innovation Careers | 2027 · Tier III | US employees in documented scientific/research-development work and professional support; role and programme eligibility applies. |
| Pharmaceutical & Biotechnology Employers | 2027 · Tier II | U.S. directly employed workforce in provider cohort; contractors and unassessed foreign affiliates excluded. |
| Employers for Employee Recognition | 2027 · Tier III | U.S. directly employed workforce in provider cohort; contractors and unassessed foreign affiliates excluded. |
Rankings and recognition
Ranking inclusion and tier classification are editorial determinations. They should be read as category-specific assessments rather than universal league-table positions. The existence or maintenance of this Wiki profile does not influence ranking eligibility, tier or position.
Related Economy analysis
Selected reporting and market analysis from The Economy provides context for the institution’s operating environment:
- Healthcare Rankings and the New Economics of Expertise
- Healthcare Market Structure Is Opening a New Lane for Specialist Providers
- Healthcare Rankings and the New Geography of Distributed Care
Related institutions and subjects
Sources and data transparency
Official institutional information, where available, is used for current public identity and capabilities. Ranking pages document 2026 category and tier status. Economy articles provide market context rather than institution-specific endorsement.
- Healthcare Ranking — Top 30 Specialty Pharma Companies 2026 — 2026 inclusion and tier classification.
- The Economy — Healthcare Rankings and the New Economics of Expertise — market context.
- The Economy — Healthcare Market Structure Is Opening a New Lane for Specialist Providers — market context.
- The Economy — Healthcare Rankings and the New Geography of Distributed Care — market context.
Corrections and Updates
Factual corrections, updated institutional information, and supporting references may be submitted through The Economy Portal. All proposed changes are subject to editorial verification before publication.